Anika Therapeutics Inc. (ANIK) financial statements (2022 and earlier)

Company profile

Business Address 32 WIGGINS AVENUE
BEDFORD, MA 01730
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments94,38690,97697,18194,59998,318124,758
Cash and cash equivalents94,38690,97697,18194,59995,817104,216
Short-term investments    2,50120,542
Receivables29,84332,35229,42626,50924,10223,009
Inventory, net of allowances, customer advances and progress billings36,01035,01942,85742,71846,20947,882
Inventory36,01035,01942,85742,71846,20947,882
Other undisclosed current assets8,2897,4338,2979,6488,7546,226
Total current assets:168,528165,780177,761173,474177,383201,875
Noncurrent Assets
Operating lease, right-of-use asset20,95721,39721,84922,32522,61922,898
Property, plant and equipment47,60249,11149,54049,13150,61351,629
Intangible assets, net (including goodwill)90,16392,97195,23397,03199,570126,710
Goodwill7,7817,9508,1498,0458,41332,419
Intangible assets, net (excluding goodwill)82,38285,02187,08488,98691,15794,291
Other noncurrent assets20,28523,67118,74820,29215,42013,226
Total noncurrent assets:179,007187,150185,370188,779188,222214,463
TOTAL ASSETS:347,535352,930363,131362,253365,605416,338
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities21,8057,9428,10118,76120,76316,748
Accounts payable7,6337,9428,1018,6838,9846,800
Accrued liabilities4,649  4,3524,4343,389
Employee-related liabilities9,523  5,7267,3456,559
Debt   119148163
Business combination, contingent consideration, liability4,3153,49016,87024,83013,09011,855
Other undisclosed current liabilities3,67517,33916,3963,2632,8662,373
Total current liabilities:29,79528,77141,36746,97336,86731,139
Noncurrent Liabilities
Long-term debt and lease obligation19,24019,63820,08020,54320,87946,132
Long-term debt, excluding current maturities     25,000
Operating lease, liability19,24019,63820,08020,54320,87921,132
Liabilities, other than long-term debt11,41514,46114,88018,08135,45954,616
Deferred income tax liabilities10,15712,97213,10010,73811,89512,584
Other liabilities1,2581,4891,7101,5831,244987
Business combination, contingent consideration, liability  705,76022,32041,045
Total noncurrent liabilities:30,65534,09934,96038,62456,338100,748
Total liabilities:60,45062,87076,32785,59793,205131,887
Stockholders' equity
Stockholders' equity attributable to parent287,085290,060286,804276,656272,400284,451
Common stock144144144144143142
Additional paid in capital67,08163,86460,69957,28155,35552,505
Accumulated other comprehensive loss(5,718)(5,319)(4,852)(5,051)(4,542)(5,296)
Retained earnings225,578231,371230,813224,282221,444237,100
Total stockholders' equity:287,085290,060286,804276,656272,400284,451
TOTAL LIABILITIES AND EQUITY:347,535352,930363,131362,253365,605416,338

Income statement (P&L) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
Revenues35,82139,53638,14534,29232,68831,694
Cost of revenue(17,687)(16,513)(17,333)(13,318)(15,944)(16,551)
Cost of goods and services sold(17,687)(16,513)(17,333)(13,318)(15,944)(14,351)
Gross profit:18,13423,02320,81220,97416,74415,143
Operating expenses(26,432)(25,173)(25,282)(24,536)(47,187)(23,070)
Other undisclosed operating income (loss)(825)3,45013,6504,82012,490 
Operating income (loss):(9,123)1,3009,1801,258(17,953)(7,927)
Interest and debt expense    (3)(7)
Other undisclosed loss from continuing operations before equity method investments, income taxes(19)     
Income (loss) from continuing operations before equity method investments, income taxes:(9,142)1,3009,1801,258(17,956)(7,934)
Other undisclosed loss from continuing operations before income taxes(28)(48)(50)(43)(181)(221)
Income (loss) from continuing operations before income taxes:(9,170)1,2529,1301,215(18,137)(8,155)
Income tax expense (benefit)3,377(694)(2,599)1,6232,4811,744
Net income (loss) available to common stockholders, diluted:(5,793)5586,5312,838(15,656)(6,411)

Comprehensive Income ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
Net income (loss):(5,793)5586,5312,838(15,656)(6,411)
Other comprehensive income (loss) (467)199(509) 522
Other undisclosed comprehensive income (loss)(1,176)   1,356 
Comprehensive income (loss):(6,969)916,7302,329(14,300)(5,889)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent777   (602) 
Comprehensive income (loss), net of tax, attributable to parent:(6,192)916,7302,329(14,902)(5,889)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: